Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Healthtrust
Boehringer Ingelheim
Chinese Patent Office
Daiichi Sankyo
Cantor Fitzgerald
Queensland Health
Merck
Teva

Generated: February 19, 2019

DrugPatentWatch Database Preview

Drug Price Trends for CEVIMELINE HCL

« Back to Dashboard

Drug Price Trends for CEVIMELINE HCL

Average Pharmacy Cost for CEVIMELINE HCL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Glossary
Drug Name NDC Price/Unit ($) Unit Date
CEVIMELINE HCL 30 MG CAPSULE 60505-3145-05 1.14687 EACH 2019-01-23
CEVIMELINE HCL 30 MG CAPSULE 63304-0479-01 1.14687 EACH 2019-01-23
CEVIMELINE HCL 30 MG CAPSULE 00054-0334-25 1.14687 EACH 2019-01-23
CEVIMELINE HCL 30 MG CAPSULE 60505-3145-01 1.14687 EACH 2019-01-23
CEVIMELINE HCL 30 MG CAPSULE 16571-0657-10 1.14687 EACH 2019-01-23
CEVIMELINE HCL 30 MG CAPSULE 60505-3145-05 1.24235 EACH 2018-12-19
CEVIMELINE HCL 30 MG CAPSULE 60505-3145-01 1.24235 EACH 2018-12-19
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for CEVIMELINE HCL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
EVOXAC 30MG CAP Daiichi Sankyo, Inc. 63395-0201-13 100 203.93 2.03930 EACH 2018-04-15 - 2023-04-14 Big4
EVOXAC 30MG CAP Daiichi Sankyo, Inc. 63395-0201-13 100 694.37 6.94370 EACH 2018-04-15 - 2023-04-14 FSS
EVOXAC 30MG CAP Daiichi Sankyo, Inc. 63395-0201-13 100 527.72 2019-01-01 - 2023-04-14 Big4
EVOXAC 30MG CAP Daiichi Sankyo, Inc. 63395-0201-13 100 694.37 2019-01-01 - 2023-04-14 FSS
CEVIMELINE HCL 30MG CAP West-Ward Pharmaceuticals Corporation 00054-0334-25 100 98.49 0.98490 EACH 2015-12-21 - 2020-12-20 FSS
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Dow
Fish and Richardson
Cantor Fitzgerald
Express Scripts
UBS
Colorcon
Citi
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: